Shereen Oon

Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study.

Kathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Jan Wu, Jiacai Cho, Aisha Lateef, CS Lau, Yi-Hsing Chen, Sandra Navarra, Leonid Zamora, Zhanguo Li, Yuan An, Sargunan Sockalingam, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Yasuhiro Katsumata, et al.

Journal article  |  2023  |  Arthritis Rheumatol

OBJECTIVE: In trials of systemic lupus erythematosus (SLE), the SLE Responder Index (SRI) is the most commonly used primary effica..

Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study.

Rangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, Yeong-Jian J Wu, Yi-Hsing Chen, Vera Golder, Aisha Lateef, Jiacai Cho, Sandra V Navarra, Leonid Zamora, Laniyati Hamijoyo, Sargunan Sockalingam, Yuan An, Zhanguo Li, Ricardo Montes, Shereen Oon, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, et al.

Journal article  |  2022  |  Arthritis Care Res (Hoboken)

OBJECTIVE: Evidence for the utility of medications in settings lacking randomized trial data can come from studies of treatment pe..

Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study

K Connelly, R Kandane-Rathnayake, A Hoi, W Louthrenoo, L Hamijoyo, J Cho, A Lateef, S Fen Luo, YJJ Wu, Z Li, S Navarra, L Zamora, S Sockalingam, Y Hao, Z Zhang, Y Katsumata, M Harigai, S Oon, M Chan, YH Chen, et al.

Journal article  |  2022  |  The Lancet Rheumatology

Background: The selection and categorisation of laboratory tests in disease activity measures used within systemic lupus erythemat..

Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

R Kandane-Rathnayake, V Golder, W Louthrenoo, YH Chen, J Cho, A Lateef, L Hamijoyo, SF Luo, YJJ Wu, SV Navarra, L Zamora, Z Li, S Sockalingam, Y Katsumata, M Harigai, Y Hao, Z Zhang, BMDB Basnayake, M Chan, J Kikuchi, et al.

Journal article  |  2022  |  The Lancet Rheumatology

Background: Treat-to-target goals for patients with systemic lupus erythematosus (SLE) have been validated to protect against orga..

Response to: 'Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?' by Chessa et al.

Anca Askanase, Shereen Oon, Molla Huq, Alicia Calderone, Eric F Morand, Mandana Nikpour, Cynthia Aranow

Journal article  |  2022  |  Ann Rheum Dis

Response to: 'Phsician's global assessment is often useful in SLE, but not always: the case of clinical remission' by Zen et al.

Anca Askanase, Shereen Oon, Molla Huq, Alicia Calderone, Eric F Morand, Mandana Nikpour, Cynthia Aranow

Journal article  |  2022  |  Ann Rheum Dis

'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study.

Rangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, Shue-Fen Luo, Yeong-Jian J Wu, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Sandra V Navarra, Leonid Zamora, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Jun Kikuchi, Tsutomu Takeuchi, et al.

Journal article  |  2022  |  Arthritis Res Ther

BACKGROUND: The unmet need in systemic lupus erythematosus (SLE) with the current standard of care is widely recognised, but few s..

Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort

Yanjie Hao, Shereen Oon, Lanlan Ji, Dai Gao, Yong Fan, Yan Geng, Xiaohui Zhang, Guangtao Li, Eric F Morand, Mandana Nikpour, ZhuoLi Zhang

Journal article  |  2021  |  CLINICAL RHEUMATOLOGY

OBJECTIVE: To investigate the frequency and determinants of achieving the lupus low disease activity state (LLDAS), and the effect..

Correspondence to 'Time to change the primary outcome of lupus trials'

Shereen Oon, Molla Huq, Mandana Nikpour

Journal article  |  2021  |  ANNALS OF THE RHEUMATIC DISEASES

Refractory discoid lupus erythematosus responds to rituximab.

Blake P Mumford, Zahra Assarian, Shereen Oon, Alvin H Chong

Journal article  |  2021  |  Australas J Dermatol